ARTICLE SUMMARY:
Many patients have a poor prognosis after suffering acute myocardial infarction, despite successful recanalization of the blocked coronary artery. Microvascular obstruction is emerging as a target for intervention in many of those patients, and CorFlow aims to be the first to develop a platform to diagnose and treat it.
When a patient suffers a heart attack due to the complete occlusion of a coronary artery, a situation that’s known as ST-segment Elevation Myocardial Infarction (STEMI), the principle therapeutic strategy is to get the artery opened as quickly as possible to restore blood flow, since the longer the heart is deprived of blood, the more cardiac tissue will die.
